Fathom Pharma

Hummelstown, United States Founded: 2019 • Age: 7 yrs Acquired By Consegna
Manufacturing of injectables is provided by this CDMO.

About Fathom Pharma

Fathom Pharma is a Healthcare company based in Hummelstown (United States) founded in 2019, and was acquired by Consegna in April 2022. Manufacturing of injectables is provided by this CDMO. Fathom Pharma offers products and services including Long-Acting Injectable Pain Therapeutics. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Exela Pharma, Summit Biosciences and ApiJect; 2 of its 3 listed competitors have raised funding.

Company details

Fathom Pharma was established in 2019 and is based in Hummelstown, United States. Contract development and manufacturing services for injectable pharmaceuticals are offered within the biopharmaceutical sector. Operations focus on producing sterile injectables, with adherence to regulatory requirements ensured for client needs. The company supports pharmaceutical partners through specialized production processes in a controlled environment.

  • Headquarters Hummelstown, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website fathompharma.com
  • Acquired by Consegna (Apr 2022)
Key Metrics

Products & Services of Fathom Pharma

Fathom Pharma offers a comprehensive portfolio of products and services, including Long-Acting Injectable Pain Therapeutics.

Long-Acting Injectable Pain Therapeutics
Pain Management

Delivers non-abusable drugs for effective pain relief with reduced abuse risks.

Investors in Fathom Pharma

Fathom Pharma has secured backing from 1 investor. Prominent investors backing the company include Consegna.

All
InvestorDescriptionFounded YearDomainLocation
Cloud migration and management services for AWS are provided.
2016consegna.cloudWellington, New Zealand
Premium access

Investor details for Fathom Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Fathom Pharma

2 dated milestones of Fathom Pharma across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Fathom Pharma is founded.
  2. Exit Acquired by Consegna.

Competitors of Fathom Pharma

Fathom Pharma has 3 listed competitors in our database, 2 of them funded. They include Exela Pharma, Summit Biosciences and ApiJect.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
exelapharma.com2005Lenoir, United States$7.09M247
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
summitbiosciences.com2008Lexington, United States
Nasal spray drug products are developed, manufactured, and commercialized.
apiject.com2015Stamford, United States$111M
Medicine injectors are manufactured by ApiJect for medical applications.
Premium access

Detailed competitors of Fathom Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Fathom Pharma (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Fathom Pharma

Fathom Pharma was founded in 2019.

Fathom Pharma is headquartered in Hummelstown, United States. It is registered at Hummelstown, Pennsylvania, United States.

Fathom Pharma was established in 2019 and is based in Hummelstown, United States. Contract development and manufacturing services for injectable pharmaceuticals are offered within the biopharmaceutical sector. Operations focus on producing sterile injectables, with adherence to regulatory requirements ensured for client needs. The company supports pharmaceutical partners through specialized production processes in a controlled environment.

Fathom Pharma's top competitors include Exela Pharma, Summit Biosciences and ApiJect.

Fathom Pharma offers Long-Acting Injectable Pain Therapeutics.

Fathom Pharma has 1 investor. Key investors include Consegna.

Yes. Fathom Pharma was acquired by Consegna in April 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available